Improve your bottom line and enhance
patient care with the Quest MPS 3 ND.
Discover how at QuestMPS3.com
Learn more at QuestMPS3.com or call us at 1.800.627.0226
© 2024 Quest Medical, Inc. All rights reserved. MPS is a registered trademark of Quest Medical, Inc. 2024-02
1 MARC W GERDISCH, ET AL. CLINICAL AND ECONOMIC BENEFITS OF ADVANCED MICROPLEGIA DELIVERY SYSTEM IN CARDIAC SURGERY:
EVIDENCE FROM 250 HOSPITALS. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH 2018; APRIL: 673-683
Eliminate the Need for
Compounding Pharmacies
Smar ter Myocardial Protection
™
The innovative design of the Quest
®
MPS 3
ND System does not rely on compounding
pharmacies, instead it allows drawing drugs
directly from the vial. This method can reduce
pharmacy expenses and reduce waste.
MICROPLEGIA WITH THE QUEST MPS SYSTEM VERSUS TRADITIONAL CARDIOPLEGIA
1
Reduction
in adverse events
Reduction
in medication costs
Reduction
in hospital costs
Patients
1 day less
Discharge
1 day earlier
Better
patient outcomes
